VERONICA CRAWLEY: Open Payments
NPI 1922366442 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,932 in 164 payments from 28 companies in 2025. Trend: 2023 $3,214 · 2024 $3,034 · 2025 $2,932
Food & beverage: $2,932
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $466 |
| ABBVIE INC. | 33 | $405 |
| Novo Nordisk Inc | 23 | $394 |
| GlaxoSmithKline, LLC. | 11 | $212 |
| PFIZER INC. | 11 | $210 |
| Amgen Inc. | 15 | $205 |
| Esperion Therapeutics, Inc. | 7 | $131 |
| Corcept Therapeutics | 5 | $105 |
| Astellas Pharma US Inc | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
Products named: FARXIGA, Ozempic, UBRELVY, TRELEGY ELLIPTA, NEXLETOL, AIRSUPRA, VRAYLAR, NURTEC ODT.
Industry payments across TN — which companies pay providers there.
